1. Biomedical research: information on federal contributions to remdesivir : report to Congressional addressees Publication: Washington, DC : United States Government Accountability Office, March 2021 Subject(s): Antiviral Agents -- economicsCOVID-19 -- economicsDrug Development -- legislation & jurisprudenceGovernment RegulationUnited States
